Is Vivoryon Therapeutics NV stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Vivoryon Therapeutics NV pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 15th of March 2022 were paid €0.285 per share. Over the last 1 times between 2022 and 2022, Vivoryon Therapeutics NV has paid €0.285 with an average of €0.29 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Vivoryon Therapeutics NV 10 years ago, but if you had invested on Tuesday 1st of February 2022 when the price was €13.38, you would have made a loss of €-11.34 per share or -84.75%
No, the average daily trading liquidity for Vivoryon Therapeutics NV is €3 012 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Vivoryon Therapeutics NV has no real debt, which is good in periods of high inflation. Vivoryon Therapeutics NV has a very good net profit margin of 861.46% and should have very high tolerances against inflation.
We have calculated the inflation risk for Vivoryon Therapeutics NV to be low [0.3 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.